Sinopharm’s two vaccines have over 70% efficacy in Phase III trials

About This Source - CGTN

This story is an English language news item from CGTN. CGTN is a Chinese state-funded broadcaster.

Recent from CGTN:

  • Golden Goblet Awards presented at Shanghai Film Festival
  • New evidence suggests novel coronavirus was in the U.S. by Christmas 2019
  • Live: Heroic stories from then and now of Communist Party of China
  • CGTN published this video item, entitled “Sinopharm’s two vaccines have over 70% efficacy in Phase III trials” – below is their description.

    For more:

    https://news.cgtn.com/news/2021-05-27/Sinopharm-s-two-vaccines-have-over-70-efficacy-in-Phase-III-trials-10BtoxirXCU/index.html

    Chinese #vaccine manufacturer #Sinopharm claims two of its COVID-19 vaccines have over 70 percent efficacy based on Phase Three clinical trials on inactivated vaccines. According to the first detailed results of a large late-stage study published in the Journal of the American Medical Association on Wednesday, the two inactivated vaccines demonstrated efficacies of 72.8 percent and 78.1 percent. #Coronavirus

    CGTN YouTube Channel

    Got a comment? Leave your thoughts in the comments section, below. Please note comments are moderated before publication.

    In This Story: COVID-19

    Covid-19 is the official WHO name given to the novel coronavirus which broke out in late 2019 and began to spread in the early months of 2020.

    Symptoms of coronavirus

    The main symptoms of coronavirus are:

    • a persistent new cough (non productive, dry)
    • a high temperature (e.g. head feels warm to the touch)
    • shortness of breath (if this is abnormal for the individual, or increased)

    Latest News about Covid-19

    Below are stories from around the globe related to the 2020 outbreak of novel Coronavirus – since the WHO gave the Covid-19 naming. Most recent items are posted nearest the top.

    5 Recent Items: COVID-19

  • New evidence suggests novel coronavirus was in the U.S. by Christmas 2019
  • Covid: Queues at pop-up vaccine centres amid jabs push @BBC News live 🔴 BBC
  • Emergency meeting called amid altered vaccine advice | Coronavirus | 9 News Australia
  • COVID impact holding back plan to increase number of women in STEM | ABC News
  • IN FULL: Chief Nurse Alison McMillan gives a COVID-19 vaccine update | ABC News
  • In This Story: Sinopharm

    China National Pharmaceutical Group Corp. known as Sinopharm is a Chinese state-owned enterprise. The corporation was the indirect major shareholder of publicly traded companies Sinopharm Group, China Traditional Chinese Medicine. Shanghai Shyndec Pharmaceutical and Beijing Tiantan Biological Products.

    2 Recent Items: Sinopharm

  • China approves Sinopharm and Sinovac jabs for emergency use for children aged 3 to 17
  • WHO-approved China-made vaccines: Impact on global COVID-19 response
  • Leave a Comment